Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    January 2017
  1. MENARD A, Aherfi S, Mokhtari S, Dhiver C, et al
    Toward chronic hepatitis C eradication in HIV-positive patients, including those cirrhotic and infected with genotype 3 viruses.
    Gut. 2017 Jan 10. pii: gutjnl-2016-313431. doi: 10.1136/gutjnl-2016-313431.
    PubMed     Text format    


    August 2016

  2. Erratum: Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.
    Gut. 2016;65:1394.
    PubMed     Text format    


    July 2016
  3. HACKSTEIN CP, Assmus LM, Welz M, Klein S, et al
    Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis.
    Gut. 2016 Jul 18. pii: gutjnl-2015-311224. doi: 10.1136/gutjnl-2015-311224.
    PubMed     Text format     Abstract available


    June 2016
  4. BHARDWAJ A, Kedarisetty CK, Vashishtha C, Bhadoria AS, et al
    Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial.
    Gut. 2016 Jun 13. pii: gutjnl-2016-311735. doi: 10.1136/gutjnl-2016-311735.
    PubMed     Text format     Abstract available


    May 2016
  5. NJEI B, McCarty TR, Garcia-Tsao G
    Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters.
    Gut. 2016 May 20. pii: gutjnl-2016-312129. doi: 10.1136/gutjnl-2016-312129.
    PubMed     Text format    


    April 2016
  6. O'BRIEN A, China L
    Is human albumin solution really the best resuscitation fluid for patients with advanced cirrhosis?
    Gut. 2016 Apr 27. pii: gutjnl-2016-311999. doi: 10.1136/gutjnl-2016-311999.
    PubMed     Text format    


  7. BOYD A, Bottero J, Lacombe K
    The gamma-glutamyl transpeptidase-to-platelet ratio as a predictor of liver fibrosis in patients co-infected with HBV and HIV.
    Gut. 2016;65:718-20.
    PubMed     Text format    


    March 2016
  8. BRITO-AZEVEDO A, Perez RM, Coelho HS, Fernandes ES, et al
    Propranolol improves endothelial dysfunction in advanced cirrhosis: the 'endothelial exhaustion' hypothesis.
    Gut. 2016 Mar 16. pii: gutjnl-2016-311696. doi: 10.1136/gutjnl-2016-311696.
    PubMed     Text format    


  9. KALAMBOKIS GN, Baltayiannis G, Christou L, Christodoulou D, et al
    Red signs and not severity of cirrhosis should determine non-selective beta-blocker treatment in Child-Pugh C cirrhosis with small varices: increased risk of hepatorenal syndrome and death beyond 6 months of propranolol use.
    Gut. 2016 Mar 2. pii: gutjnl-2016-311527. doi: 10.1136/gutjnl-2016-311527.
    PubMed     Text format    


  10. ZHAO XL, Yang JR, Lin SZ, Ma H, et al
    Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV.
    Gut. 2016;65:502-11.
    PubMed     Text format     Abstract available


  11. ICHOU L, Carbonell N, Rautou PE, Laurans L, et al
    Ascitic fluid TREM-1 for the diagnosis of spontaneous bacterial peritonitis.
    Gut. 2016;65:536-8.
    PubMed     Text format    


    January 2016
  12. STOCKDALE AJ, Phillips RO, Geretti AM
    The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptida
    Gut. 2016 Jan 4. pii: gutjnl-2015-311133. doi: 10.1136/gutjnl-2015-311133.
    PubMed     Text format    


    December 2015
  13. HU HH, Liu J, Lin YL, Luo WS, et al
    The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Gut. 2015 Dec 7. pii: gutjnl-2015-310686. doi: 10.1136/gutjnl-2015-310686.
    PubMed     Text format     Abstract available


    October 2015
  14. NAHON P, Lescat M, Layese R, Bourcier V, et al
    Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).
    Gut. 2015 Oct 28. pii: gutjnl-2015-310275. doi: 10.1136/gutjnl-2015-310275.
    PubMed     Text format     Abstract available


    September 2015
  15. KLEIN S, Rick J, Lehmann J, Schierwagen R, et al
    Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
    Gut. 2015 Sep 17. pii: gutjnl-2015-309600. doi: 10.1136/gutjnl-2015-309600.
    PubMed     Text format     Abstract available


  16. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.
    Gut. 2015 Sep 14. pii: gutjnl-2015-310593. doi: 10.1136/gutjnl-2015-310593.
    PubMed     Text format    


    August 2015
  17. ZEISEL MB, Lucifora J, Mason WS, Sureau C, et al
    Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.
    Gut. 2015;64:1314-26.
    PubMed     Text format     Abstract available


    July 2015
  18. COOMBES JD, Swiderska-Syn M, Dolle L, Reid D, et al
    Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.
    Gut. 2015;64:1120-31.
    PubMed     Text format     Abstract available


    June 2015
  19. LEMOINE M, Shimakawa Y, Nayagam S, Khalil M, et al
    The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
    Gut. 2015 Jun 24. pii: gutjnl-2015-309260. doi: 10.1136/gutjnl-2015-309260.
    PubMed     Text format     Abstract available


  20. ZHANG DY, Goossens N, Guo J, Tsai MC, et al
    A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection.
    Gut. 2015 Jun 4. pii: gutjnl-2015-309655. doi: 10.1136/gutjnl-2015-309655.
    PubMed     Text format     Abstract available


  21. BEDRELI S, Sowa JP, Gerken G, Saner FH, et al
    Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis.
    Gut. 2015 Jun 3. pii: gutjnl-2015-309922. doi: 10.1136/gutjnl-2015-309922.
    PubMed     Text format    


    May 2015
  22. TAKUMA Y, Nouso K, Morimoto Y, Tomokuni J, et al
    Prediction of oesophageal variceal bleeding by measuring spleen stiffness in patients with liver cirrhosis.
    Gut. 2015 May 25. pii: gutjnl-2015-309741. doi: 10.1136/gutjnl-2015-309741.
    PubMed     Text format    


  23. LEE YA, Wallace MC, Friedman SL
    Pathobiology of liver fibrosis: a translational success story.
    Gut. 2015;64:830-41.
    PubMed     Text format     Abstract available


    April 2015
  24. TRIPATHI D, Stanley AJ, Hayes PC, Patch D, et al
    UK guidelines on the management of variceal haemorrhage in cirrhotic patients.
    Gut. 2015 Apr 17. pii: gutjnl-2015-309262. doi: 10.1136/gutjnl-2015-309262.
    PubMed     Text format     Abstract available


  25. MOREAU R
    Stimulating hepatocyte renewal: a new paradigm for the treatment of severe alcoholic hepatitis unresponsive to corticosteroids?
    Gut. 2015 Apr 3. pii: gutjnl-2015-309545. doi: 10.1136/gutjnl-2015-309545.
    PubMed     Text format    


  26. RAMOS JM, Vidal I, Bellot P, Gomez-Hurtado I, et al
    Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis.
    Gut. 2015 Apr 1. pii: gutjnl-2015-309421. doi: 10.1136/gutjnl-2015-309421.
    PubMed     Text format    


  27. PLOMPEN EP, Hansen BE, Schouten JN, Darwish Murad S, et al
    Interferon gamma receptor 2 gene variants are associated with liver fibrosis in the general population: the Rotterdam Study.
    Gut. 2015;64:692-4.
    PubMed     Text format    


    March 2015
  28. GIANNINI EG, Savarino V
    An independent validation of the mortality score for the short-term prognostic prediction in patients with chronic HCV infection and advanced liver disease.
    Gut. 2015 Mar 24. pii: gutjnl-2015-309440. doi: 10.1136/gutjnl-2015-309440.
    PubMed     Text format    


  29. DUBUQUOY L, Louvet A, Lassailly G, Truant S, et al
    Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis.
    Gut. 2015 Mar 2. pii: gutjnl-2014-308410. doi: 10.1136/gutjnl-2014-308410.
    PubMed     Text format     Abstract available


    February 2015
  30. MORALES-IBANEZ O, Affo S, Rodrigo-Torres D, Blaya D, et al
    Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesis.
    Gut. 2015 Feb 4. pii: gutjnl-2014-307979. doi: 10.1136/gutjnl-2014-307979.
    PubMed     Text format     Abstract available


    January 2015
  31. ANGELI P, Gines P, Wong F, Bernardi M, et al
    Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.
    Gut. 2015 Jan 28. pii: gutjnl-2014-308874. doi: 10.1136/gutjnl-2014-308874.
    PubMed     Text format    


  32. WAIDMANN O, Kempf VA, Brandt C, Zeuzem S, et al
    Colonisation with multidrug-resistant bacteria is associated with increased mortality in patients with cirrhosis.
    Gut. 2015 Jan 23. pii: gutjnl-2014-309104. doi: 10.1136/gutjnl-2014-309104.
    PubMed     Text format    


  33. TREBICKA J, Schierwagen R
    Statins, Rho GTPases and KLF2: new mechanistic insight into liver fibrosis and portal hypertension.
    Gut. 2015 Jan 16. pii: gutjnl-2014-308800. doi: 10.1136/gutjnl-2014-308800.
    PubMed     Text format    


  34. TRIVEDI PJ, Lammers WJ, van Buuren HR, Pares A, et al
    Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.
    Gut. 2015 Jan 7. pii: gutjnl-2014-308351. doi: 10.1136/gutjnl-2014-308351.
    PubMed     Text format     Abstract available


    December 2014
  35. JOOSSE ME, Schipper ME, Libbrecht L, Buuren HR, et al
    Recurrent cholangitis in a 65-year-old man.
    Gut. 2014 Dec 22. pii: gutjnl-2014-308726. doi: 10.1136/gutjnl-2014-308726.
    PubMed     Text format    


  36. MARRONE G, Maeso-Diaz R, Garcia-Cardena G, Abraldes JG, et al
    KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.
    Gut. 2014 Dec 10. pii: gutjnl-2014-308338. doi: 10.1136/gutjnl-2014-308338.
    PubMed     Text format     Abstract available


  37. YAPALI S, Lok AS
    Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV?
    Gut. 2014;63:1833-4.
    PubMed     Text format    


  38. EHLING J, Bartneck M, Wei X, Gremse F, et al
    CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.
    Gut. 2014;63:1960-71.
    PubMed     Text format     Abstract available


    November 2014
  39. KRAG A, Madsen BS
    To block, or not to block in advanced cirrhosis and ascites: that is the question.
    Gut. 2014 Nov 14. pii: gutjnl-2014-308424. doi: 10.1136/gutjnl-2014-308424.
    PubMed     Text format    


  40. WANG X, Lopategi A, Ge X, Lu Y, et al
    Osteopontin induces ductular reaction contributing to liver fibrosis.
    Gut. 2014;63:1805-18.
    PubMed     Text format     Abstract available


    September 2014
  41. RUEGER S, Bochud PY, Dufour JF, Mullhaupt B, et al
    Impact of common risk factors of fibrosis progression in chronic hepatitis C.
    Gut. 2014 Sep 11. pii: gutjnl-2014-306997. doi: 10.1136/gutjnl-2014-306997.
    PubMed     Text format     Abstract available


  42. BARTOSCH B
    Piecing together the key players of fibrosis in chronic hepatitis C: what roles do non-hepatic liver resident cell types play?
    Gut. 2014 Sep 8. pii: gutjnl-2014-307957. doi: 10.1136/gutjnl-2014-307957.
    PubMed     Text format    


    August 2014
  43. BEILFUSS A, Sowa JP, Sydor S, Beste M, et al
    Vitamin D counteracts fibrogenic TGF-beta signalling in human hepatic stellate cells both receptor-dependently and independently.
    Gut. 2014 Aug 18. pii: gutjnl-2014-307024. doi: 10.1136/gutjnl-2014-307024.
    PubMed     Text format     Abstract available


    July 2014
  44. FLORIMOND A, Chouteau P, Bruscella P, Le Seyec J, et al
    Human hepatic stellate cells are not permissive for hepatitis C virus entry and replication.
    Gut. 2014 Jul 25. pii: gutjnl-2013-305634. doi: 10.1136/gutjnl-2013-305634.
    PubMed     Text format     Abstract available


  45. STRAZZABOSCO M, Fabris L, Albano E
    Osteopontin: a new player in regulating hepatic ductular reaction and hepatic progenitor cell responses during chronic liver injury.
    Gut. 2014 Jul 23. pii: gutjnl-2014-307712. doi: 10.1136/gutjnl-2014-307712.
    PubMed     Text format    


  46. MACHADO MV, Michelotti GA, Pereira TD, Boursier J, et al
    Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.
    Gut. 2014 Jul 22. pii: gutjnl-2014-307362. doi: 10.1136/gutjnl-2014-307362.
    PubMed     Text format     Abstract available


  47. ARNDT S, Wacker E, Dorn C, Koch A, et al
    Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease.
    Gut. 2014 Jul 10. pii: gutjnl-2014-306968. doi: 10.1136/gutjnl-2014-306968.
    PubMed     Text format     Abstract available


  48. LIM TH, Gane E, Moyes C, Borman B, et al
    Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Maori: results from a 28-year follow-up study.
    Gut. 2014 Jul 8. pii: gutjnl-2013-306247. doi: 10.1136/gutjnl-2013-306247.
    PubMed     Text format     Abstract available


    June 2014
  49. NEUMANN-HAEFELIN C, Thimme R
    Prediction of clinical outcome in advanced hepatitis C-associated liver disease: identification of patients at the highest need for antiviral treatment and surveillance.
    Gut. 2014 Jun 19. pii: gutjnl-2014-307490. doi: 10.1136/gutjnl-2014-307490.
    PubMed     Text format    


  50. REVILL P, Locarnini S
    Viral factors and predicting disease outcomes in chronic hepatitis B.
    Gut. 2014 Jun 11. pii: gutjnl-2014-307398. doi: 10.1136/gutjnl-2014-307398.
    PubMed     Text format    


    May 2014
  51. MEJIAS M, Coch L, Berzigotti A, Garcia-Pras E, et al
    Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats.
    Gut. 2014 May 21. pii: gutjnl-2014-307138. doi: 10.1136/gutjnl-2014-307138.
    PubMed     Text format     Abstract available


  52. VAN DER MEER AJ, Hansen BE, Fattovich G, Feld JJ, et al
    Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters.
    Gut. 2014 May 9. doi: 10.1136/gutjnl-2013-305357.
    PubMed     Text format     Abstract available


    April 2014
  53. AFFO S, Sancho-Bru P
    CCL2: a link between hepatic inflammation, fibrosis and angiogenesis?
    Gut. 2014 Apr 2. doi: 10.1136/gutjnl-2014-306905.
    PubMed     Text format    


    March 2014
  54. CHO JY, Paik YH, Sohn W, Cho HC, et al
    Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.
    Gut. 2014 Mar 10. doi: 10.1136/gutjnl-2013-306409.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: